<DOC>
	<DOC>NCT00396448</DOC>
	<brief_summary>The purpose of this study is to examine the long-term weight loss and safety of CP-945,598 in obese adults</brief_summary>
	<brief_title>Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.</brief_title>
	<detailed_description>The CP-945,598 program was terminated on November 3, 2008 due to changing regulatory perspectives on the risk/benefit profile of the CB1 class and likely new regulatory requirements for approval. No safety issues were involved in the termination decision.</detailed_description>
	<criteria>Obese adults with a body mass index &gt; or = 30 kg/m ; &gt; or = 27 kg/m2 for those with obesityrelated comorbidities including hypertension and dyslipidemia Pregnancy Diabetes Adults with serious or unstable current or past medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>